Remove 2018 Remove Clinic Remove Community Remove Diagnosis
article thumbnail

Intersections Between Gender, Race/Ethnicity and Marital Status Associations with Depression Symptoms [Behavioral, psychosocial, and mental illness]

Annals of Family Medicine

Context: Depression remains a prevalent mental health condition, with rates of diagnosis disproportionately increasing for women and Black or Hispanic adults. Setting or Dataset: Data were derived from a survey dataset obtained from NHANES, specifically cross-sectional data from the 2013 to 2018 waves.

Illness 130
article thumbnail

Overtreatment of prostate cancer in the active surveillance era

Common Sense Family Doctor

Concerns about overdiagnosis of clinically insignificant prostate cancer through prostate specific antigen (PSA) screening motivated the 2018 American Academy of Family Physicians’ (AAFP) recommendation against routine screening for prostate cancer. Watchful waiting refers to clinical observation only.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Proposes Select Updates to the Breakthrough Devices Program Designed to Reduce Health Care Disparities

FDA Law

This draft guidance proposes updates to FDA’s Breakthrough Devices Program, which is outlined in a separate December 2018 guidance document. FDA intends to incorporate these updates into the December 2018 Breakthrough Devices Program guidance after considering public comment.

article thumbnail

PEMPix 2024 Online Case #2: Flight of Passage

PEMBlog

PEMPix is the American Academy of Pediatrics Section on Emergency Medicine’s annual visual diagnosis competition. What’s the Diagnosis? Most patients are afebrile by the third day of treatment and clinically improved within two weeks. Time course of symptom resolution in patients with community-acquired pneumonia.

article thumbnail

District Court Interprets EKRA

FDA Law

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. A) to induce a referral of an individual to a recovery home, clinical treatment facility, or laboratory; or. (B)

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law

Comments, including data from research and clinical practice, that provides evidence that an alternate maximum day supply (other than the proposed 30-day supply). The Act also established new definitions for “Internet,” “online pharmacy,” “practice of telemedicine,” among others. 21 U.S.C. § 802(54)(D)(i).

article thumbnail

District Court Interprets EKRA

FDA Law

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. A) to induce a referral of an individual to a recovery home, clinical treatment facility, or laboratory; or. (B)